Skip to content
Screener

Zoetis ZTS Restructuring Charges And Acquisition And Divestiture Related Costs

Restructuring Charges And Acquisition And Divestiture Related Costs at other companies

Jabil logo
JabilJBL
$3M-66.7%
Novanta logo
NovantaNOVT
$12.5M-0.6%
Tenet Healthcare logo
Tenet HealthcareTHC
$31M+29.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$31M+29.2%
Rambus logo
RambusRMBS
$0-100%
Pfizer logo
PfizerPFE
$457M+2,639%

Other financials

Income statement

See full
Revenue$2.5B-0.2%
Gross profit$1.8B-0.8%
Net income$691.0M-4.8%
EPS (diluted)$1.65+1.2%

Balance sheet

See full
Cash & equivalents$1.5B-9.6%
Total debt$10.0B+47.1%
Total equity$3.1B-36.7%
Total assets$15.1B+4.1%

Cash flow

See full
Operating cash flow$655.0M+8.3%
CapEx$117.0M-19.9%
Free cash flow$538.0M+17.2%

Valuation

See full
Market cap$32.39B-50.1%
Enterprise value$40.91B-41.6%
P/E12.4×-12.7×
P/S3.4×-3.5×

Profitability

See full
Gross margin71.5%+0.2pp
Net margin27.5%-0.1pp
FCF margin24.3%+0.1pp

Returns & leverage

See full
Return on equity64.4%+12.3pp
Debt / equity3.2×+1.8×
Current ratio3.1×+1.3×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept zts:RestructuringChargesAndAcquisitionAndDivestitureRelatedCosts.

The source filing: Zoetis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 2:32 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001555280-26-000040
(MILLIONS OF DOLLARS)Three Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Restructuring charges and certain acquisition and divestiture-related costs:
Acquisition-related costs$2$1$4$1
Restructuring charges, net(a):
Employee termination costs, net745945
Asset impairment charges2222
Exit costs1212
Total Restructuring charges and certain acquisition and divestiture-related costs$77$30$99$30

Item 1. Financial Statements

FAQ

What is Zoetis's restructuring charges and acquisition and divestiture related costs?
Zoetis (ZTS) reported restructuring charges and acquisition and divestiture related costs of $77M in Q2 2026.
How has Zoetis's restructuring charges and acquisition and divestiture related costs changed year-over-year?
Zoetis's restructuring charges and acquisition and divestiture related costs increased by 156.7% year-over-year, from $30M to $77M.
What is the long-term trend for Zoetis's restructuring charges and acquisition and divestiture related costs?
Over 3 years (2022 to 2025), Zoetis's restructuring charges and acquisition and divestiture related costs has grown at a 66.7% compound annual growth rate (CAGR), from $11M to $51M.
What does restructuring charges and acquisition and divestiture related costs mean?
Restructuring charges and acquisition-related costs represent one-time or non-recurring expenses incurred during organizational changes, business integrations, or divestitures. These costs include severance, facility closures, and professional fees associated with corporate transactions. Investors monitor these to distinguish between core operational performance and transitory corporate events.

Ask your AI about Zoetis's restructuring charges and acquisition and divestiture related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude